Pulmonology Practice Questions

Q: Which of the following is typically not associated with allergic pulmonary aspergillosis?

Occurrence in patients with old cavitary lesions. Occurrence in patients with old cavitary lesions - Allergic bronchopulmonary aspergillosis (ABPA) primarily affects patients with **asthma** or **cystic fibrosis**, causing an allergic response to *Aspergillus* spores within the airways. - The presence of old cavitary lesions is a hallmark of **aspergilloma**, a distinct form of aspergillus infection, rather than ABPA [1]. *High IgE level* - ABPA is characterized by an intense **T-helper 2 immune response** to *Aspergillus* antigens, leading to significantly elevated total and *Aspergillus*-specific **IgE levels**. - **Serological tests** showing high IgE are a key diagnostic criterion for ABPA. *Pleural effusion* - While less common, **pleural effusions** can occur in severe cases of ABPA, typically due to associated **pneumonitis** or bronchial obstruction. - It indicates significant inflammatory involvement beyond the airways. *Recurrent pneumonia* - Patients with ABPA often experience recurrent episodes of **pulmonary infiltrates**, which can clinically present as recurrent pneumonia. - These episodes are due to **bronchial obstruction** by mucus plugs and inflammatory reactions to the fungus, leading to localized inflammation and consolidation [1].

Q: Which of the following is used for improving the long-term prognosis in COPD with resting hypoxemia?

Oxygen. ***Oxygen*** - **Long-term oxygen therapy** (LTOT) in patients with COPD and resting hypoxemia significantly improves **survival**, quality of life, and exercise capacity [2], [3]. - It reduces the risk of developing **pulmonary hypertension** and **cor pulmonale** [3]. *Beta-2 agonist* - **Short-acting** and **long-acting beta-2 agonists** are bronchodilators used to relieve symptoms like breathlessness by relaxing airways [1]. - While they improve symptoms and exercise tolerance, they do not impact the **long-term prognosis** or survival in COPD [1]. *Inhaled steroids* - **Inhaled corticosteroids** (ICS) are primarily used to reduce the frequency of **exacerbations** in patients with severe COPD. - They do not directly improve **long-term survival** or alter the progression of lung function decline. *Systemic steroids* - **Systemic corticosteroids** are used for short-term treatment of acute COPD exacerbations to reduce inflammation. - **Chronic use** is associated with significant side effects and does not improve the long-term prognosis or survival in stable COPD.

Q: A 53-year-old male smoker, unemployed with no occupational exposure, is admitted with progressive shortness of breath. He has been unwell for some time and has received multiple courses of antibiotics for "bronchitis." During the prior 4 months, he has not had any medical follow-up. On examination, he is afebrile but looks ill. Lung examination reveals diffuse rhonchi and crackles with no localizing signs. Arterial blood gases on room air show a PaO2 of 68 mmHg with mild compensated respiratory alkalosis. Sputum for acid-fast bacilli is negative. Chest X-ray is shown. What is associated with this diagnosis?

Clubbing. ***Clubbing*** - The chest x-ray shows a **reticulonodular pattern** with **hilar lymphadenopathy**, consistent with **sarcoidosis**. - **Digital clubbing** can be observed in about 2-3% of patients with sarcoidosis, especially in those with advanced pulmonary fibrosis. *Increased IgE* - **Elevated IgE levels** are more characteristic of **allergic bronchopulmonary aspergillosis (ABPA)** or **severe allergic asthma**, not sarcoidosis. - While sarcoidosis is an immune-mediated disease, its primary immunological feature involves T-cell dysregulation and granuloma formation, not typically IgE-mediated hypersensitivity. *Hypocalcemia* - **Hypercalcemia**, not hypocalcemia, is a known complication of sarcoidosis due to **increased calcitriol production** by activated macrophages in granulomas. - Granulomas produce **1-alpha hydroxylase**, which converts 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D (calcitriol), leading to increased calcium absorption. *Eosinophilia* - **Eosinophilia** is not a typical feature of sarcoidosis. The disease is characterized by a Th1-mediated immune response. - Significant eosinophilia in lung disease often suggests **allergic conditions**, **parasitic infections**, or **certain drug reactions**.

Q: Right middle lobe syndrome (Middle lobe syndrome) most commonly affects which lobe of the lung?

Right middle lobe. ***Right middle lobe*** - **Right middle lobe syndrome** is, by definition, a collapse and consolidation of the **right middle lobe** of the lung. - This syndrome is characterized by recurrent or persistent atelectasis and/or pneumonitis specifically in the **right middle lobe** due to its unique anatomical features [1]. *Right lower lobe* - The **right lower lobe** is a distinct anatomical area of the lung and is not directly involved in **right middle lobe syndrome** [1]. - While it can be affected by other lung pathologies, **right middle lobe syndrome** specifically impacts the middle lobe. *Left upper lobe* - The **left upper lobe** is located in the left lung and is not associated with the **right middle lobe syndrome** [1]. - Its anatomy and associated pathologies are separate from those affecting the middle lobe of the right lung. *Left lower lobe* - Similar to the left upper lobe, the **left lower lobe** belongs to the left lung and is not involved in **right middle lobe syndrome**. - Lung conditions affecting the **left lower lobe** would be distinct from this syndrome.

Q: pH 7.24, PaO2 55 mm Hg, PaCO2 55 mm Hg, and HCO3- 30 mEq/L are consistent with which acid-base disorder?

Respiratory acidosis. ***Respiratory acidosis*** - The **low pH (7.24)** indicates acidosis [1]. The **elevated PaCO2 (55 mm Hg)**, which is an acid, is primarily responsible for this drop in pH, indicating a respiratory problem [1]. - The **elevated HCO3- (30 mEq/L)** suggests a **renal compensatory response** to chronic respiratory acidosis, attempting to buffer the excess acid [2]. *Metabolic acidosis* - This would be characterized by a **low pH** and a **low bicarbonate (HCO3-)** level, which is not seen here as HCO3- is elevated [1]. - While there is acidosis, the primary driver is the elevated PaCO2, not a fall in bicarbonate. *Metabolic alkalosis* - This condition would present with a **high pH** and an elevated bicarbonate (HCO3-) level [3]. The given pH is low, indicating acidosis. - The elevated bicarbonate alone is often a **compensatory mechanism** rather than the primary disorder [3]. *Respiratory alkalosis* - This would involve a **high pH** and a **low PaCO2**, indicating hyperventilation [1]. The given pH is low, and PaCO2 is elevated. - This patient is hypoventilating, leading to CO2 retention and acidosis, not alkalosis [1].

Q: A 65-year-old male presents to the emergency department with acute respiratory distress, decreased breath sounds, and stony dullness to percussion on the right side. What is the initial management for this patient?

Thoracentesis of the right chest cavity. ***Thoracentesis of the right chest cavity*** - This patient presents with **acute respiratory distress**, **decreased breath sounds**, and **stony dullness to percussion** on the right side, which are classic signs of a **large pleural effusion**. - **Thoracentesis** (needle aspiration of pleural fluid) is the immediate intervention to relieve pressure on the lung, allow for re-expansion, and improve breathing. - This procedure provides both diagnostic information (analyzing pleural fluid) and therapeutic relief. *Pericardiocentesis* - This procedure is performed to drain fluid from the **pericardial sac** in cases of **cardiac tamponade** (Beck's triad: hypotension, muffled heart sounds, JVP elevation). - The patient's symptoms of decreased breath sounds, dullness to percussion, and unilateral findings point to a **pleural** issue, not a cardiac one. *Echocardiogram* - An **echocardiogram** is an imaging test used to visualize the heart's structure and function and assess for pericardial effusions. - While useful for diagnosis, it is **not an initial management step** to relieve acute respiratory distress caused by a pleural effusion. - In emergency settings with clear clinical signs, **therapeutic intervention takes priority** over diagnostic imaging. *Pericardial window* - A **pericardial window** is a surgical procedure to create an opening in the pericardium, typically for recurrent or loculated pericardial effusions. - This is a **definitive surgical treatment** and not an initial emergency management for acute respiratory distress from pleural pathology.

Q: Blood gas measurements of a patient show the following values: pH 7.2, pCO2 80 mm Hg, and pO2 46 mm Hg. Which of the following could be the most probable diagnosis?

Acute exacerbation of COPD. ***Acute exacerbation of COPD*** - The patient presents with **respiratory acidosis** (pH 7.2, normal 7.35-7.45) and **hypercapnia** (pCO2 80 mm Hg, normal 35-45 mm Hg), combined with severe **hypoxemia** (pO2 46 mm Hg, normal 80-100 mm Hg) [2]. - This pattern is highly indicative of an acute exacerbation of **Chronic Obstructive Pulmonary Disease**, where worsening airflow obstruction leads to inadequate alveolar ventilation and impaired gas exchange; clinical evidence suggests long-term oxygen therapy can decrease mortality in these chronic patients [1]. *Acute bronchospasm* - While acute bronchospasm can cause hypoxemia and hypercapnia, the degree of hypercapnia (pCO2 80 mm Hg) seen here is typically more severe and prolonged than commonly observed in isolated bronchospasm. Indications for assisted ventilation in severe asthma include a rising PaCO2 above 45 mmHg [3]. - Acute bronchospasm would likely result in less pronounced acidosis and more rapid response to bronchodilator therapy, which isn't described. *Pulmonary embolism* - Pulmonary embolism typically causes **hypoxemia** and **hypocapnia** (low pCO2) due to reflex hyperventilation in response to V/Q mismatch, which contradicts the presented blood gas values [2]. - The primary defect in pulmonary embolism is an obstruction of blood flow, not a global ventilation impairment leading to severe hypercapnia. *Chronic pneumonia* - Chronic pneumonia can cause **hypoxemia** due to V/Q mismatch or shunting, but it generally leads to **hypocapnia** or normal pCO2 if the patient is able to compensate by increasing ventilation [2]. - Severe hypercapnia (pCO2 80 mm Hg) with acute acidosis is less typical for uncomplicated chronic pneumonia, unless it's a very advanced or acute severe presentation with respiratory muscle fatigue.

Q: Which of the following structures is not seen on bronchoscopy?

Subcarinal lymph nodes. ***Subcarinal lymph nodes*** - While the **carina** (the division of the trachea into the main stem bronchi) is clearly visible, the **lymph nodes** located beneath it are external to the airway and cannot be directly visualized during a standard bronchoscopy. - Visualization of lymph nodes typically requires imaging studies like CT scans or invasive procedures like **endobronchial ultrasound (EBUS)** with biopsy. *Trachea* - The **trachea** is the main airway tube and is fully visualized during the initial insertion and advancement of the bronchoscope. - Its rings, mucosa, and antegrade lumen are clearly inspected. *Vocal cords* - The **vocal cords** are located in the larynx, superior to the trachea, and are the first structures encountered and assessed during the intubation phase of a bronchoscopy. - Their movement and appearance are routinely checked to ensure proper bronchoscope insertion. *First segmental division of bronchi* - Bronchoscopy allows for the visualization of the **main bronchi** and their subsequent divisions down to the **segmental and subsegmental bronchi**. - The first division branches are readily accessible and are a common area for inspection and biopsy.

Q: Pulmonary embolism is seen in all except?

Fanconi anemia. ***Fanconi anemia*** - **Fanconi anemia** is a genetic disorder characterized by **bone marrow failure**, physical abnormalities, and an increased risk of cancer. - It does **not typically involve an increased risk of pulmonary embolism** as a primary manifestation; instead, its complications relate to cytopenias and malignancy. *Paroxysmal nocturnal hemoglobinuria* - **Paroxysmal nocturnal hemoglobinuria (PNH)** is strongly associated with **thrombosis**, including pulmonary embolism, due to acquired defects in the PIGA gene leading to complement-mediated red blood cell lysis. - The loss of **GPI-anchored proteins** (CD55 and CD59) on blood cells makes them susceptible to complement attack, promoting a prothrombotic state. *Oral contraception* - **Oral contraceptives**, particularly those containing **estrogen**, significantly increase the risk of venous thromboembolism, including pulmonary embolism. - Estrogens increase the synthesis of **clotting factors** and decrease natural anticoagulants. *Old age* - **Advanced age** is a well-established risk factor for **venous thromboembolism (VTE)**, including pulmonary embolism. - This is due to age-related changes such as reduced mobility, increased prevalence of comorbidities, and altered coagulation profiles.

Q: All are causes of pulmonary hypertension except which of the following?

Hyperventilation. ***Hyperventilation*** - **Hyperventilation** leads to a decrease in arterial carbon dioxide (PaCO2), causing **respiratory alkalosis** [1]. - This alkalosis induces **pulmonary vasodilation**, which tends to decrease rather than increase pulmonary arterial pressure. *Morbid obesity* - **Morbid obesity** often leads to **obesity hypoventilation syndrome (OHS)**, characterized by chronic hypoxemia and hypercapnia. - The resulting **chronic hypoxemia** causes sustained pulmonary vasoconstriction, leading to pulmonary hypertension. *High altitude* - Living at **high altitude** exposes individuals to **chronic hypoxia** due to lower atmospheric partial pressure of oxygen [3]. - This triggers **hypoxic pulmonary vasoconstriction** as a physiological response, which over time can remodel the pulmonary vasculature and lead to pulmonary hypertension [2]. *Fenfluramine* - **Fenfluramine** is an appetite suppressant that was historically linked to the development of pulmonary hypertension. - It causes an increase in pulmonary vascular resistance through various mechanisms, including enhancing the release and inhibiting the reuptake of **serotonin**, a potent pulmonary vasoconstrictor.

Question 1

Which of the following is typically not associated with allergic pulmonary aspergillosis?

Accepted Answer

Occurrence in patients with old cavitary lesions

Answer

High IgE level

Answer

Pleural effusion

Answer

Recurrent pneumonia

Question 2

Which of the following is used for improving the long-term prognosis in COPD with resting hypoxemia?

Accepted Answer

Oxygen

Answer

Beta-2 agonist

Answer

Inhaled steroids

Answer

Systemic steroids

Question 3

A 53-year-old male smoker, unemployed with no occupational exposure, is admitted with progressive shortness of breath. He has been unwell for some time and has received multiple courses of antibiotics for "bronchitis." During the prior 4 months, he has not had any medical follow-up. On examination, he is afebrile but looks ill. Lung examination reveals diffuse rhonchi and crackles with no localizing signs. Arterial blood gases on room air show a PaO2 of 68 mmHg with mild compensated respiratory alkalosis. Sputum for acid-fast bacilli is negative. Chest X-ray is shown. What is associated with this diagnosis?

Accepted Answer

Clubbing

Answer

Increased IgE

Answer

Hypocalcemia

Answer

Eosinophilia

Question 4

Right middle lobe syndrome (Middle lobe syndrome) most commonly affects which lobe of the lung?

Accepted Answer

Right middle lobe

Answer

Right lower lobe

Answer

Left upper lobe

Answer

Left lower lobe

Question 5

pH 7.24, PaO2 55 mm Hg, PaCO2 55 mm Hg, and HCO3- 30 mEq/L are consistent with which acid-base disorder?

Accepted Answer

Respiratory acidosis

Answer

Metabolic acidosis

Answer

Metabolic alkalosis

Answer

Respiratory alkalosis

Question 6

A 65-year-old male presents to the emergency department with acute respiratory distress, decreased breath sounds, and stony dullness to percussion on the right side. What is the initial management for this patient?

Accepted Answer

Thoracentesis of the right chest cavity

Answer

Echocardiogram

Answer

Pericardial window

Answer

Pericardiocentesis

Question 7

Blood gas measurements of a patient show the following values: pH 7.2, pCO2 80 mm Hg, and pO2 46 mm Hg. Which of the following could be the most probable diagnosis?

Accepted Answer

Acute exacerbation of COPD

Answer

Acute bronchospasm

Answer

Pulmonary embolism

Answer

Chronic pneumonia

Question 8

Which of the following structures is not seen on bronchoscopy?

Accepted Answer

Subcarinal lymph nodes

Answer

Trachea

Answer

Vocal cords

Answer

First segmental division of bronchi

Question 9

Pulmonary embolism is seen in all except?

Accepted Answer

Fanconi anemia

Answer

Oral contraception

Answer

Old age

Answer

Paroxysmal nocturnal hemoglobinuria

Question 10

All are causes of pulmonary hypertension except which of the following?

Accepted Answer

Hyperventilation

Answer

High altitude

Answer

Fenfluramine

Answer

Morbid obesity

Pulmonology — MCQs

Pulmonology — MCQs

On this page

Practice by Chapter

Want unlimited practice?